Oncology & Cancer

Increased toxicity for many newly approved anticancer drugs

(HealthDay)—Newly approved anticancer drugs that do not have a specific molecular target on cancer cells are associated with increased toxicity and the accompanying costs of management, according to research published online ...

Oncology & Cancer

Blood cancer cells initiate signalling cascade

Researchers in the group of Prof. Dr. Hassan Jumaa, Centre for Biological Signalling Studies (BIOSS) of the University of Freiburg, Department for Molecular Immunology, have identified a new mechanism that causes immune cells ...

Medications

Combination of 2 drugs reverses liver tumors

The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research ...

Oncology & Cancer

MRI technique could reduce need for breast biopsies

A magnetic resonance (MR) breast imaging technique that uses no ionizing radiation or contrast agent could reduce unnecessary biopsies by providing additional information about suspicious findings on X-ray screening mammography, ...

Oncology & Cancer

Scientists find a molecule to fight chemoresistant cancer

A team of Russian scientists led by MIPT's Prof. Alexander Kiselyov has synthesized an antitumor compound that could be used to fight chemoresistant cancer. The research findings were published in the European Journal of ...

Oncology & Cancer

New cancer 'tracer' promises to detect more tumors earlier

For people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to researchers at the University of Alberta, a new medical imaging agent for PET scans promises to reduce wait times, ...

page 12 from 25